Highlights Virbac

Equities

Market Closed - Euronext Paris Other stock markets 11:35:20 2024-04-29 am EDT			5-day change	1st Jan Change
349 ^EUR	0.00%		-7.18%	-2.92%

Apr. 17	VIRBAC : A healthy start to 2024; outlook re-iterated
Apr. 17	Virbac: sales up by almost 10% in Q1	CF

VIRBAC : A healthy start to 2024; outlook re-iterated	Apr. 17
Virbac: sales up by almost 10% in Q1	Apr. 17	CF
Virbac: 'strategic' acquisition of Sasaeah in Japan	Apr. 02	CF
Virbac SA acquired Sasaea Holdings Co., Ltd. from ORIX Corporation.	Mar. 31	CI
VIRBAC : Oddo BHF maintains its recommendation on the stock	Mar. 21	CF
CAC40: damage limited despite Kering's fall	Mar. 20	CF
Virbac: net income unchanged overall in 2023	Mar. 20	CF
Virbac Sa Provides Earnings Guidance for the Year 2024	Mar. 19	CI
Virbac Sa Proposes Dividend for the Year 2023	Mar. 19	CI
Virbac SA Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 18	CI
Virbac to Buy Orix's Animal Health Unit	Mar. 06	MT
Virbac: acquisition of Sasaeah in Japan	Mar. 06	CF
Virbac SA entered into a definitive agreement to acquire Sasaea Holdings Co., Ltd. from ORIX Corporation for an enterprise value of approximately ?280 million.	Mar. 05	CI
VIRBAC : Modest beat in Q4; 2024 outlook maintained	Jan. 18
VIRBAC : Stifel raises its target price	Jan. 18	CF
Virbac: sales up 4.6% in 2023	Jan. 17	CF
Virbac SA Provides Earnings Guidance for the Year 2024	Jan. 17	CI
Virbac: one of the SBF120's top performers in 2023	Dec. 29	CF
France's Virbac Takes Majority Stake in Indian Poultry Vaccines Group Globion	Nov. 03	MT
Virbac acquires majority stake in Globion	Nov. 02	CF

No results for this search

VIRBAC : A healthy start to 2024; outlook re-iterated

April 17, 2024 at 12:39 pm EDT